Screener
AnaptysBio, Inc. ANAB Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | March 31, 2026(unaudited) | December 31, 2025 |
|---|---|---|
| Receivables from collaborative partners | 25,747 | 33,850 |
| Short-term investments | 37,986 | 73,442 |
| Prepaid expenses and other current assets | 3,907 | 4,762 |
| Total current assets | 316,109 | 350,250 |
| Property and equipment, net | 1,280 | 1,370 |
| Operating lease right-of-use assets | 12,039 | 12,519 |
| Other long-term assets | 256 | 256 |
| Total assets | $329,684 | $364,395 |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s total current assets?
- AnaptysBio, Inc. (ANAB) reported total current assets of $316.11M in Q1 2026.
- How has AnaptysBio, Inc.'s total current assets changed year-over-year?
- AnaptysBio, Inc.'s total current assets decreased by 12.9% year-over-year, from $363.11M to $316.11M.
- What is the long-term trend for AnaptysBio, Inc.'s total current assets?
- Over 5 years (2020 to 2025), AnaptysBio, Inc.'s total current assets has grown at a -2.5% compound annual growth rate (CAGR), from $396.56M to $350.25M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about AnaptysBio, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude